As a result of the current Federal government funding situation, the information on this website may not be up to date or acted upon.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit https://cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at https://www.opm.gov.

PDQ® Cancer Genetics Editorial Board

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

This Editorial Board consists of experts in the fields of genetics, clinical oncology, epidemiology, psychology, and the social sciences. This editorial board meets five times a year, and the primary purpose is to develop and maintain PDQ cancer information summaries pertaining to the field of cancer genetics.

  • Mary B. Daly, M.D., Ph.D., Editor-in-Chief
    Fox Chase Cancer Center
    Philadelphia, PA
  • Doreen Agnese, M.D.
    The Ohio State University
    Columbus, OH
  • Kathleen A. Calzone, Ph.D., R.N., A.P.N.G., F.A.A.N.
    National Cancer Institute
    Bethesda, MD
  • Ilana Cass, M.D.
    Cedars-Sinai Medical Center
    Los Angeles, CA
  • Lee-may Chen, M.D.
    UCSF Helen Diller Family Comprehensive Cancer Center
    San Francisco, CA
  • Veda N. Giri, M.D.
    Thomas Jefferson University
    Philadelphia, PA
  • Donald Hadley, M.S., C.G.C.
    National Human Genome Research Institute
    Bethesda, MD
  • Joanne Jeter, M.D., M.S.
    The Ohio State University
    Columbus, OH
  • Eric Jonasch, M.D.
    University of Texas, M.D. Anderson Cancer Center
    Houston, TX
  • Fay Kastrinos, M.D., M.P.H.
    Herbert Irving Comprehensive Cancer Center
    New York-Presbyterian Hospital/Columbia University Medical Center
    New York, NY
  • Scott Kuwada, M.D., A.G.A.F., F.A.C.P.
    University of Hawaii
    Honolulu, HI
  • Jennifer K. Litton, M.D.
    University of Texas, M.D. Anderson Cancer Center
    Houston, TX
  • Patrick Lynch, M.D., J.D.
    University of Texas, M.D. Anderson Cancer Center
    Houston, TX
  • Sarah Nielsen, M.S., L.C.G.C.
    The University of Chicago
    Chicago, IL
  • Suzanne O'Neill, Ph.D., M.S., C.G.C.
    Northwestern University
    Chicago, IL
  • Tuya Pal, M.D.
    Vanderbilt-Ingram Cancer Center
    Nashville, TN
  • Nancy D. Perrier, M.D., F.A.C.S.
    University of Texas, M.D. Anderson Cancer Center
    Houston, TX
  • Beth N. Peshkin, M.S., C.G.C.
    Lombardi Comprehensive Cancer Center at Georgetown University Medical Center
    Washington, DC
  • Susan Peterson, Ph.D., M.P.H.
    University of Texas, M.D. Anderson Cancer Center
    Houston, TX
  • Mark Pomerantz, M.D.
    Dana-Farber Cancer Institute
    Boston, MA
  • Miguel Rodriguez-Bigas, M.D.
    University of Texas, M.D. Anderson Cancer Center
    Houston, TX
  • Brian M. Shuch, M.D.
    Yale University School of Medicine
    New Haven, CT
  • Jennifer Sipos, M.D.
    The Ohio State University
    Columbus, OH
  • Ramaprasad Srinivasan, M.D., Ph.D.
    National Cancer Institute
    Bethesda, MD
  • Mary Beth Terry, Ph.D.
    Columbia University Mailman School of Public Health
    New York, NY
  • Amanda E. Toland, Ph.D., F.A.C.M.G.
    The Ohio State University
    Columbus, OH
  • Danielle Kim Turgeon, M.D.
    University of Michigan Comprehensive Cancer Center
    Ann Arbor, MI
  • Susan T. Vadaparampil, Ph.D., M.P.H.
    H. Lee Moffitt Cancer Center & Research Institute
    Tampa, FL
  • Catharine Wang, Ph.D., M.Sc.
    Boston University School of Public Health
    Boston, MA
  • Matthew B. Yurgelun, M.D.
    Dana-Farber Cancer Institute
    Boston, MA
  • Kevin Zbuk, M.D., F.R.C.P.C.
    Margaret and Charles Juravinski Cancer Centre
    Hamilton, Ontario, Canada
  • Updated: May 9, 2017